S'pore drug development gets another shot in the arm
One goal for EDDC will be to create projects that are attractive to multinational pharmaceutical companies
Add BT as a preferred source
Singapore
A*STAR officially opened the new Experimental Drug Development Centre (EDDC) on Wednesday to take more made-in-Singapore drugs from early-stage drug discovery to clinical trials and commercialisation.
Towards this end, the statutory board also launched the Target Translation Consortium (TTC), which coordinates drug discovery efforts in academia, healthcare institutions and government agencies, and consolidated three existing A*Star grants into the Singapore Therapeutics Development Review (STDR).
TRENDING NOW
Nvidia will soon face a chip limit, warns Huawei’s top scientist
Cold Storage moves into convenience retail with On The Go, to replace FairPrice at 58 Esso stations
Yeoh Pei Xien: YTL’s third-gen scion with a pastor’s heart
Three Arrows going after founder Zhu Su’s wife for US$40 million from Dubai property sale
